Edition:
United Kingdom

Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

93.02USD
15 Dec 2017
Change (% chg)

$4.49 (+5.07%)
Prev Close
$88.53
Open
$90.27
Day's High
$93.02
Day's Low
$88.56
Volume
1,412,405
Avg. Vol
454,311
52-wk High
$100.50
52-wk Low
$80.10

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.26 December 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 9 8 8 8
(2) OUTPERFORM 11 11 11 10
(3) HOLD 4 5 5 5
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.79 1.88 1.88 1.87

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 19 352.03 454.00 330.60 353.74
Quarter Ending Mar-18 9 341.72 362.97 318.31 364.70
Year Ending Dec-17 24 1,305.61 1,409.00 1,285.80 1,316.93
Year Ending Dec-18 24 1,488.31 1,550.00 1,424.00 1,574.39
Earnings (per share)
Quarter Ending Dec-17 15 -0.26 -0.12 -0.43 -0.32
Quarter Ending Mar-18 9 -0.20 0.02 -0.70 -0.02
Year Ending Dec-17 17 -0.65 -0.50 -0.81 -1.09
Year Ending Dec-18 20 -0.26 0.64 -1.34 -0.19
LT Growth Rate (%) 1 25.00 25.00 25.00 25.00

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 347.41 334.15 13.26 3.82
Quarter Ending Jun-17 308.77 317.45 8.67 2.81
Quarter Ending Mar-17 288.93 303.74 14.81 5.13
Quarter Ending Dec-16 295.96 300.09 4.13 1.40
Quarter Ending Sep-16 289.44 279.90 9.55 3.30
Earnings (per share)
Quarter Ending Sep-17 -0.14 -0.07 0.07 -48.57
Quarter Ending Jun-17 -0.21 -0.21 0.00 -0.62
Quarter Ending Mar-17 -0.29 -0.09 0.20 -68.45
Quarter Ending Dec-16 -0.38 -0.53 0.15 -39.25
Quarter Ending Sep-16 -0.39 -0.26 0.13 -32.57

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 352.03 352.29 348.60 340.21 353.74
Quarter Ending Mar-18 341.72 341.98 345.87 351.49 364.70
Year Ending Dec-17 1,305.61 1,306.03 1,302.60 1,315.84 1,316.93
Year Ending Dec-18 1,488.31 1,487.21 1,496.70 1,505.33 1,574.39
Earnings (per share)
Quarter Ending Dec-17 -0.26 -0.27 -0.27 -0.32 -0.32
Quarter Ending Mar-18 -0.20 -0.20 -0.13 -0.14 -0.02
Year Ending Dec-17 -0.65 -0.65 -0.66 -0.72 -1.09
Year Ending Dec-18 -0.26 -0.30 -0.26 -0.25 -0.19

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 1 1 2
Quarter Ending Mar-18 0 1 1 1
Year Ending Dec-17 0 2 1 2
Year Ending Dec-18 2 0 2 1
Earnings
Quarter Ending Dec-17 1 0 1 1
Quarter Ending Mar-18 0 0 1 2
Year Ending Dec-17 1 0 2 0
Year Ending Dec-18 1 0 2 1